Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

2.7K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2026
Same author

Immediate prediction of post-ERCP pancreatitis: a novel approach using serum trypsin.

Journal of gastroenterology·2026
Same author

Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry.

Cancers·2026
Same author

Reply to "Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients".

Journal of gastroenterology·2026
Same author

Comparison of Nanoliposomal Irinotecan Plus Fluorouracil/Leucovorin and S-1, Irinotecan, and Oxaliplatin as Second-Line Chemotherapy After Gemcitabine Plus Nab-Paclitaxel for Unresectable Pancreatic Cancer.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

EUS-HGS with antegrade stenting vs. hepaticogastrostomy alone for malignant biliary drainage: Systematic review and meta-analysis.

Endoscopy international open·2026

Related Experiment Video

Updated: Jan 12, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.5K

Endobiliary radiofrequency ablation for malignant biliary obstruction.

Hirofumi Yamazaki1, Yasunobu Yamashita1, Masayuki Kitano2

  • 1Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Therapeutic Advances in Gastroenterology
|November 3, 2025
PubMed
Summary

Endoscopic radiofrequency ablation (eRFA) shows promise for malignant biliary obstruction (MBO), improving survival when combined with stenting or chemotherapy. Further research is needed to confirm its efficacy.

Keywords:
ampullary tumorbiliary tract cancerendoscopic radiofrequency ablationmalignant biliary obstructionoverall survivalstent patency

More Related Videos

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

35.0K
Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

914

Related Experiment Videos

Last Updated: Jan 12, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.5K
Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

35.0K
Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

914

Area of Science:

  • Gastroenterology
  • Interventional Oncology
  • Biliary Interventions

Background:

  • Malignant biliary obstruction (MBO) is a serious condition often managed with percutaneous or endoscopic interventions.
  • Radiofrequency ablation (RFA) and endoscopic radiofrequency ablation (eRFA) are emerging techniques for MBO.
  • Current evidence for eRFA is largely based on retrospective studies, necessitating further investigation.

Purpose of the Study:

  • To summarize and clarify the current status and applications of radiofrequency ablation for malignant biliary obstruction.
  • To review the efficacy of endoscopic radiofrequency ablation in various clinical scenarios.
  • To identify areas for future research in eRFA for MBO.

Main Methods:

  • Systematic review and meta-analysis of existing studies on eRFA for MBO.
  • Analysis of eRFA in combination with biliary stenting and chemotherapy.
  • Evaluation of eRFA for occluded self-expandable metal stents (SEMSs) and inoperable ampullary tumors.

Main Results:

  • eRFA with biliary stenting improved overall survival at 6 months but not stent patency.
  • Combination of eRFA and chemotherapy improved overall survival and progression-free survival in locally-advanced biliary tract cancer.
  • eRFA extended time to recurrent obstruction for occluded SEMSs and improved outcomes for inoperable ampullary tumors.

Conclusions:

  • eRFA demonstrates therapeutic effects in various applications for MBO, including improved survival and symptom management.
  • While promising, further large-scale prospective studies are required to strengthen the evidence base for eRFA.
  • Future research should explore synergistic effects, such as combining eRFA with immune-checkpoint inhibitors.